These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36837761)

  • 1. GAPDH Is a Novel Ferroptosis-Related Marker and Correlates with Immune Microenvironment in Lung Adenocarcinoma.
    Ouyang X; Zhu R; Lin L; Wang X; Zhuang Q; Hu D
    Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment.
    Huang D; Tang E; Zhang T; Xu G
    Front Immunol; 2022; 13():916284. PubMed ID: 35860256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma.
    Yang L; Fan X; Zhou C; Wang Z; Cui Z; Wu X; Xu Z; Yang J; Zhang X
    Transl Lung Cancer Res; 2023 Aug; 12(8):1766-1781. PubMed ID: 37691861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a ferroptosis-based model to predict prognosis, tumor microenvironment, and drug response for lung adenocarcinoma with weighted genes co-expression network analysis.
    Cheng T; Shan G; Yang H; Gu J; Lu C; Xu F; Ge D
    Front Pharmacol; 2022; 13():1072589. PubMed ID: 36467089
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
    Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
    Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.
    Lu L; Liu LP; Zhao QQ; Gui R; Zhao QY
    Front Oncol; 2021; 11():675545. PubMed ID: 34249715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma.
    Wang Y; Chen W; Zhu M; Xian L
    Front Mol Biosci; 2021; 8():692530. PubMed ID: 34395526
    [No Abstract]   [Full Text] [Related]  

  • 10. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
    Li F; Niu Y; Zhao W; Yan C; Qi Y
    Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma.
    Deng B; Xiang J; Liang Z; Luo L
    Cancer Cell Int; 2022 Sep; 22(1):292. PubMed ID: 36153508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients.
    Zhang N; Wu Y; Wu Y; Wang L; Chen J; Wang X; Chard Dunmall LS; Cheng Z; Wang Y
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment.
    Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X
    Front Immunol; 2022; 13():903758. PubMed ID: 36016939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma.
    Li H; Ge Y; Fei G; Wang Z; Wang S; Wei P
    Transl Cancer Res; 2022 Oct; 11(10):3620-3633. PubMed ID: 36388044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a copper metabolism-related gene signature in lung adenocarcinoma.
    Chang W; Li H; Zhong L; Zhu T; Chang Z; Ou W; Wang S
    Front Immunol; 2022; 13():1040668. PubMed ID: 36524120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients.
    Cai J; Li C; Li H; Wang X; Zhou Y
    PeerJ; 2021; 9():e11931. PubMed ID: 34434660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas.
    Mao K; Tang R; Wu Y; Zhang Z; Gao Y; Huang H
    Front Genet; 2023; 14():1118273. PubMed ID: 36923797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
    Gao X; Tang M; Tian S; Li J; Liu W
    Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma.
    Zhang A; Yang J; Ma C; Li F; Luo H
    Front Cell Dev Biol; 2021; 9():616271. PubMed ID: 34249899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.